May 2022

Abstract 2: VTE Risk in Patients With Subsegmental PE Without Anticoagulation

EMA 2022 May26 Chapters

  1. Introduction6:06
  2. Ultra Summary33:55
  3. Time To Talk A Little Nerdy: Peer Review23:28
  4. Farewell2:41

Playback Speed

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Rabbott -

With no treatment group, how can we know if it better, worse, or identical to anticoagulate or not anticoagulate? If the general risk of recurrent VTE in currently anticoagulated patients is roughly the same as in non-anticoagulated, why on earth would we treat them?
I would think that this study provides us only with a background rate of VTE and invites a comparison study to determine if anticoagulation might be beneficial or not.
This study provides no data that would support a hypothesis that anticoagulation would be superior to observation in a population with a very low chance of progression or recurrence. prompt consideration of anticoaguation. Treatment might be a good idea, but this study doesn't provide any objective support for such an idea.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To earn CME for this chapter, you need to subscribe.

Sign up today for full access to all episodes and earn CME.

6 AMA PRA Category 1 Credits™ certified by PIM

  1. Quiz Not Required
  2. Complete Evaluation
  3. Print Certificate